AtaiBeckley Says BPL-003 Phase 2a Data Show Rapid, Durable Antidepressant Effect In Treatment-Resistant Depression, Phase 3 On Track For Q2 2026

Benzinga Newsdesk www.benzinga.com Positive 91.9%